CAAS Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25,000
| Closed | -$555K | – | 503 |
|
|
2022
Q4 | $555K | Buy |
+25,000
| New | +$555K | 0.03% | 127 |
|
|
2021
Q4 | – | Sell |
-140,354
| Closed | -$3.46M | – | 660 |
|
|
2021
Q3 | $3.46M | Buy |
+140,354
| New | +$3.46M | 0.07% | 96 |
|
|
2020
Q4 | – | Sell |
-15,000
| Closed | -$422K | – | 593 |
|
|
2020
Q3 | $422K | Hold |
15,000
| – | – | 0.01% | 229 |
|
|
2020
Q2 | $424K | Buy |
+15,000
| New | +$424K | 0.01% | 149 |
|